Stock & Company Details
Faeth Therapeutics $FTH
Price:
N/A
N/A
26M
$225M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.06
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
FTH technical indicators
Latest Faeth Therapeutics (FTH) indicator readings as of 2026-11-19.
FTH's 14-day RSI is 24.2, in oversold territory. ADX reads 35.5, indicating a trending market. MACD (12, 26, 9) is -3.90, below the zero line.
Overview
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Finance Bot
Ask your questions
Start by typing a question below.